Negotiated reimbursement rates for D9613 across 22 states, sourced from CMS Transparency in Coverage data. 125 rate records.
D9613 is the code for the infiltration of a sustained-release therapeutic drug. This procedure is typically employed when a long-lasting effect of medication is needed, such as in the management of pain or inflammation in dental procedures. Clinical indications for this code include cases where sustained relief is necessary, and the drug's pharmacokinetics support prolonged action. Documentation should include the specific drug used, the method of administration, and the patient's response to treatment. Reimbursement for D9613 can vary by payor and state, with average reimbursement around $102. It is important for dental billing professionals to verify the specific coverage policies of each insurance provider, as some may have restrictions on the use of sustained-release medications.
Reimbursement rates for D9613 vary significantly by state, payor, and provider network. The national average negotiated rate is $102. Data sourced from CMS Transparency in Coverage machine-readable files, updated monthly.
19+ more states available with Pro ↓